Pfizer to pay record $2.3B to settle U.S. drug probe

Pfizer, the world's largest drugmaker, took a $2.3 billion charge for a record settlement of U.S. investigations into improper marketing of its Bextra painkiller and other drugs. Pfizer reached an agreement with the U.S. attorney in Massachusetts to "resolve previously disclosed investigations" regarding Bextra and "other open investigations," the New York-based company said Monday in a ...

Enter your user name and password in the fields above to gain access to the subscriber content on this site. Need a subscription? Click here.
Your subscription includes one set of login credentials for your exclusive use. Security features have been integrated on this site: If someone signs in with your credentials while you are logged in, the site will automatically close your ongoing login and you will lose access at that time.
If you feel your login credentials are being used by a second party, contact customer service at 877-615-9536 for assistance in changing your password.

Already a paid subscriber but not registered for online access yet? For instructions on how to get premium web access, click here.

Forgot your password?

MLM Counties News. Notices. Need-to-know Information.

Pfizer to pay record $2.3B to settle U.S. drug probe

Leave a Reply